HerzSupplement - Pentalong von Actavis

Herz Supplement
Cardiovascular Diseases
5. Chung SJ, Fung HL. Identification of the sub�
cellular site for nitroglycerin metabolism to
nitric oxide in bovine coronary smooth mus�
cle cells. J Pharmacol Exp Ther 1990;253(2):
614–619
6. Dupuis J, Lalonde G, Lemieux R, Rouleau JL.
Tolerance to intravenous nitroglycerin in
patients with congestive heart failure: role
of increased intravascular volume, neurohu�
moral activation and lack of prevention
with N�acetyl�cysteine. J Am Coll Cardiol
1990;16(4):923–931
7. Packer M, Lee WH, Kessler PD, Gottlieb SS, Me�
dina N, Yushak M. Prevention and reversal of
nitrate tolerance in patients with congestive
heart failure. N Engl J Med 1987;317(13):
799–804
8. Parker JD, Farrell B, Fenton T, Cohanim M,
Parker JO. Counter�regulatory responses to
continuous and intermittent therapy with
nitroglycerin. Circulation 1991;84(6):
2336–2345
9. Molina CR, Andresen JW, Rapoport RM, Wald�
man S, Murad F. Effect of in vivo nitroglycerin
therapy on endothelium�dependent and in�
dependent vascular relaxation and cyclic
GMP accumulation in rat aorta. Journal of
Cardiovascular Pharmacology 1987;10(4):
371–378
10. Axelsson KL, Andersson RG. Tolerance towards
nitroglycerin, induced in vivo, is correlated to
a reduced cGMP response and an alteration in
cGMP turnover. Eur J Pharmacol 1983;88(1):
71–79
11. Mulsch A, Busse R, Bassenge E. Desensitiza�
tion of guanylate cyclase in nitrate toler�
ance does not impair endothelium�de�
pendent responses. Eur J Pharmacol 1988;
158(3):191–198
12. Munzel T, Daiber A, Mulsch A. Explaining the
phenomenon of nitrate tolerance. Circ Res
2005;97(7):618–628
13. Mollnau H, Wenzel P, Oelze M, Treiber N,
Pautz A, Schulz E, Schuhmacher S, Reifen�
berg K, Stalleicken D, Scharffetter�Kochanek
K, Kleinert K, Munzel T, Daiber A, Mitochon�
drial oxidative stress and nitrate toler�
ance�comparison of nitroglycerin and pen�
taerithrityl tetranitrate in Mn�SOD+/– mice.
BMC Cardiovasc Disord 2006;6:44
14. Wenzel P, Oelze M, Coldewey M, Hortmann
M, Seeling A, Hink U, Mollnau H, Stalleicken
D, Weiner H, Lehmann J, Li H, Forstermann U,
Munzel T, Daiber A, Heme oxygenase�1: a
novel key player in the development of tol�
erance in response to organic nitrates. Arte�
rioscler Thromb Vasc Biol 2007;27(8):
1729–1735
15. Fink B, Bassenge E. Unexpected, tolerance�
devoid vasomotor and platelet actions of
pentaerythrityl tetranitrate. J Cardiovasc
Pharmacol 1997;30(6):831–836
16. Schwemmer M, Bassenge E. New approach�
es to overcome tolerance to nitrates. Cardio�
vasc Drugs Ther 2003;17(2):159–173
17. Dikalov S, Fink B, Skatchkov M, Stalleicken D,
Bassenge E. Formation of reactive oxygen
species by pentaerithrityltetranitrate and
glyceryl trinitrate in vitro and development
of nitrate tolerance. J Pharmacol Exp Ther
1998;286(2):938–944
18. Oberle S, Abate A, Grosser N, Hemmerle A,
Vreman HJ, Dennery PA, Schneider HT, Stal�
leicken D, Schroder H. Endothelial protection
by pentaerithrityl trinitrate: bilirubin and
carbon monoxide as possible mediators.
Exp Biol Med (Maywood) 2003;228(5):
529–534
19. Oberle S, Schwartz P, Abate A, Schroder H.
The antioxidant defense protein ferritin is a
novel and specific target for pentaerithrityl
tetranitrate in endothelial cells. Biochem
Biophys Res Commun 1999;261(1):28–34
20. Bassenge E, Schneider HT, Daiber A. Oxida�
tive stress and cardiovascular diseases.
Dtsch Med Wochenschr 2005;130(50):
2904–2909
21. Jurt U, Gori T, Ravandi A, Babaei S, Zeman P,
Parker JD. Differential effects of pentaeryth�
ritol tetranitrate and nitroglycerin on the
development of tolerance and evidence of
lipid peroxidation: a human in vivo study. J
Am Coll Cardiol 2001;38(3):854–859
22. Gori T, Al�Hesayen A, Jolliffe C, Parker JD.
Comparison of the effects of pentaerythri�
tol tetranitrate and nitroglycerin on endo�
thelium� dependent vasorelaxation in male
volunteers. Am J Cardiol 2003;91(11):
1392–1394
23. Thomas GR, DiFabio JM, Tommaso T, Parker
JD. Once Daily Therapy with Isosor�
bide�5�Mononitrate Causes Endothelial
Dysfunction in Humans: Evidence of a Free
Radical Mediated Mechanism. J Am Coll Car�
diol 2007; in press
24. Sekiya M, Sato M, Funada J, Ohtani T, Akutsu
H, Watanabe K. Effects of the long�term ad�
ministration of nicorandil on vascular endo�
thelial function and the progression of ar�
teriosclerosis. J Cardiovasc Pharmacol 2005;
46(1):63–67
25. Thum T, Fraccarollo D, Thum S, Schultheiss
M, Daiber A, Wenzel P, Munzel T, Ertl G, Bau�
ersachs J. Differential Effects of Organic Ni�
trates on Endothelial Progenitor Cells Are
Determined by Oxidative Stress. Arterioscler
Thromb Vasc Biol 2007;27:748–754
26. DiFabio JM, Thomas GR, Zucco L, Kuliszewski
MA, Bennett BM, Kutryk MJ, Parker JD. Nitro�
glycerin attenuates human endothelial pro�
genitor cell differentiation, function, and
survival. J Pharmacol Exp Ther 2006;318(1):
117–123
26a. S. Schuhmacher, P. Wenzel, E. Schulz, M. Oelze,
C. Mang, J. Kamuf, T. Gori, T. Jansen, M. Knorr,
S. Karbach, M. Hortmann, F. Mäthner, A. Bhat�
nagar, U. Förstermann, H. Li, T. Münzel, A.
Daiber. Pentaerithrityl tetranitrate improves
angiotensin II induced vascular dysfunction
via induction of heme oxygenase�1.
Hypertension 2010; DOI: 10.1161/Hyperten�
sionAHA.109. 149542
26b. B. Schnorbus, R. Schiewe, M. A. Ostad, C.
Medler, D. Wachtlin, P. Wenzel, A. Daiber, T.
Münzel, A. Warnholtz. Effects of pentaeryth�
ritol tetranitrate on endothelial function in
coronary artery disease: Results of the PEN�
TA study. Clin. Res. Cardiol. 2010; DOI
10.1007/s00392�009�0096�z
27. Pautz A, Rauschkolb P, Schmidt N, Art J, Oelze
M, Wenzel P, Forstermann U, Daiber A, Klei�
nert H. Effects of nitroglycerin or pentae�
rithrityl tetranitrate treatment on the gene
expression in rat hearts: evidence for car�
diotoxic and cardioprotective effects. Physi�
ol Genomics 2009;38(2):176–185
28. Oppermann M, Balz V, Adams V, Dao VT, Bas
M, Suvorava T, Kojda G. Pharmacological in�
duction of vascular extracellular superoxide
dismutase expression in vivo. J Cell Mol Med
2009;13(7):1271–1278
29. Dovinova I, Cacanyiova S, Faberova V, Kristek
F. The effect of an NO donor, pentaerythrityl
tetranitrate, on biochemical, functional, and
morphological attributes of cardiovascular
system of spontaneously hypertensive rats.
Gen Physiol Biophys 2009;28(1):86–93
30. Wenzel P, Schulz E, Gori T, Ostad MA, Math�
ner F, Schildknecht S, Gobel S, Oelze M, Stal�
leicken D, Warnholtz A, Munzel T, DaiberA.
Monitoring white blood cell mitochondrial
aldehyde dehydrogenase activity: implica�
tions for nitrate therapy in humans. J Phar�
macol Exp Ther 2009;330(1):63–71
31. Koenig A, Lange K, Konter J, Daiber A, Stal�
leicken D, Glusa E, Lehmann J. Potency and
in vitro tolerance of organic nitrates: par�
tially denitrated metabolites contribute to
the tolerance�devoid activity of pentaery�
thrityl tetranitrate. J Cardiovasc Pharmacol
2007; 50(1):68–74
32. Daiber A, Oelze M, Coldewey M, Bachschmid
M, Wenzel P, Sydow K, Wendt M, Kleschyov
AL, Stalleicken D, Ullrich V, Mulsch A, Munzel
T. Oxidative stress and mitochondrial alde�
hyde dehydrogenase activity: a comparison
of pentaerythritol tetranitrate with other
organic nitrates. Mol Pharmacol 2004;66(6):
1372–1382
33. Nakamura Y, Moss AJ, Brown MW, Kinoshita
M, Kawai C. Long�term nitrate use may be
deleterious in ischemic heart disease: a
study using the databases from two
large�scale postinfarction studies. Multi�
center Myocardial Ischemia Research Group.
Am Heart J 1999;138(3 Pt 1):577–585
34. Munzel T, Sayegh H, Freeman BA, Tarpey
MM, Harrison DG. Evidence for enhanced
vascular superoxide anion production in
nitrate tolerance. A novel mechanism un�
derlying tolerance and cross�tolerance. J
Clin Invest 1995;95(1):187–194
35. Chen Z, Zhang J, Stamler JS. Identification of
the enzymatic mechanism of nitroglycerin
bioactivation. Proc Natl Acad Sci U S A 2002;
99(12):8306–8311
36. Gori T, Daiber A. Non�hemodynamic effects
of organic nitrates and the distinctive char�
acteristics of pentaerithrityl tetranitrate.
Am J Cardiovasc Drugs 2009;9(1):7–15
37. Daiber A, Wenzel P, Oelze M, Schuhmacher
S, Jansen T, Munzel T. Mitochondrial alde�
hyde dehydrogenase (ALDH�2) – maker of
and marker for nitrate tolerance in response
to nitroglycerin treatment. Chem Biol Inter�
act 2009;178(1–3):40–47
38. Daiber A, Oelze M, Wenzel P, Wickramanay�
ake JM, Schuhmacher S, Jansen T, Lackner KJ,
Torzewski M, Munzel T. Nitrate tolerance as
a model of vascular dysfunction: roles for
mitochondrial aldehyde dehydrogenase and
mitochondrial oxidative stress. Pharmacol
Rep 2009;61(1):33–48
39. Kollau A, Beretta M, Russwurm M, Koesling
D, Keung WM, Schmidt K, Mayer B. Mito�
34 Herz 35 · 2010 · Supplement II © Urban & Vogel